← Back to Search

Inspiratory Muscle Training in ME/CFS and COVID-19 Survivors (Inspire ME Trial)

N/A
Waitlist Available
Led By Heather Edgell, PhD
Research Sponsored by York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if breathing exercises can help people with long-term COVID-19 symptoms or chronic fatigue syndrome by making their breathing muscles stronger. The study includes healthy people, ME/CFS patients, and COVID-19 long-haulers to see if the exercises improve their breathing and reduce symptoms. Breathing exercises have been shown to improve specific respiratory parameters in moderate to severe COVID-19 patients and can be a valuable tool for respiratory rehabilitation.

Eligible Conditions
  • Chronic Fatigue Syndrome (CFS)
  • Post-COVID Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Chemoreflex function
Clinical autonomic function
Cognitive function
+1 more
Secondary study objectives
Cardiorespiratory fitness
ME symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Inspiratory muscle trainingExperimental Treatment1 Intervention
The 8-week inspiratory muscle training protocol consists of using 80% of maximal inspiratory pressure (determined in lab), 3x per week, 6 sets of 6 repetitions. Each set will be separated by decreasing lengths of time over the 8 weeks starting at a 30 second interim. This totals 36 inhalations 3 times per week. Progress will be determined via weekly phone calls with the participants and progress will also be logged by participants over the 8 weeks.

Find a Location

Who is running the clinical trial?

York UniversityLead Sponsor
63 Previous Clinical Trials
521,351 Total Patients Enrolled
Heather Edgell, PhDPrincipal InvestigatorYork University
~11 spots leftby Dec 2025